News and Updates from the IV Therapy Summit
This IV Therapy summit will focus on advancing IV Therapy including ensuring adherence to the revised RCN Standards for Infusion Therapy and monitoring adherence to the NICE Guideline and Quality Standards for IV Therapy. The conference will focus on improving quality and safety of both inpatient IV Therapy and delivering effective IV therapy at home (OPAT).
The day is chaired by Jackie Nicholson Global Committee Member World Congress on Vascular Access & Nurse Consultant Vascular Access St George’s University Hospitals NHS Foundation Trust who gave an national and international update on IV Therapy and vascular access devices.
Jackie Portsmouth Project Board Member Revised RCN Standard for Infusion Therapy & Consultant Nurse, Infection Prevention and Control BUPA Cromwell Hospital gave an update on RCN Standards for Infusion Therapy which covered:
- the purpose of the RCN project board
- the purpose of the standards and key areas of practice
- why evidence based standards in IV Infusion Therapy are good for our patients
- how the standards can be used to support organisations to achieve outstanding results in IV Infustion Therapy
Maya Guerrero Clinical Specialist Lead, NHS Clinical Evaluation Team Department of Health CNS for Vascular Access & IV Therapy Frimley Health NHS Foundation Trust did a session on Department of Health/NHS Clinical Evaluation Team Focus Project: Safety Peripheral IV Cannula.
- Clinical Evaluation Team (Who are we? What is it that we do?) Our Clinical Evaluation Pathway; Our Clinical Engagements; Our Reports; Our team moving forwards
- Project Focus – Safety Peripheral IV Cannula Purpose; Evaluation Process; Progress of the Project
A national evaluation of safety peripheral intravenous catheters (PIVC) in the National Health Service (NHS) (A Department of Health & Social Care Initiative)
Introduction: Studies have demonstrated that around 50% of all hospital in-patients require the insertion of an intravenous catheter. The NHS spends approximately about £29 million per year on sales for PIVC with over 300 different variations of products. The PIVC national evaluation, a first of its kind, is part of a series of national project governed by the Department of Health and Social Care led by NHS Clinical Evaluation Team (CET) conducted in a robust and independent manner.
Method: This evaluation process was undertaken across all regions in England by the CET. Stakeholders’ engagements and clinical conversations took place around the country. The team utilized a five stage clinical pathway-product range assessment, intelligence gathering, stakeholder engagement, clinical criteria build, product evaluation and clinical review report.
Results: This first phase of the process has provided an opportunity to capture valuable information about what clinicians need PIVC to do. This clinician-defined criterion ensures quality, objective statements to which the next stage of the evaluation process will be based upon. PIVC design and clinical acceptability in practice will be examined. Data will be presented from the first phase of the evaluation.
Discussion and Conclusion: The majority of studies and researches about PIVCs to date have been conducted about care and management mostly in economically developed nations. Clinical acceptability studies on the other hand, are often carried out by industries as part of commercial promotion of one product against another. A comprehensive report will be providing clinical view in partnership with NHS colleagues. It will have a national significance in the procurement of PIVC which will consequently have high impact on patient care. This will ensure a high quality national catalogue of PIVC delivered for the NHS. By highlighting unmet clinical needs it will also support innovation from clinicians and industry.
Dawn Hill OPAT Specialist Nurse and Colette Gilmore OPAT Specialist Nurse Oxford University Hospitals NHS Foundation TrustDeveloping effective oupatient access to intravenous therapy: OPAT and avoiding hospital admission by providing IV Therapy treatment within a patient’s home
Andrew Barton Chair NIVAS Advanced Nurse Practitioner in Vascular Access and IV Therapy Frimley Health NHS Foundation Trust will talk about Complications and incident investigation in practice in which he talks about learning from a study into doctors knowledge of fluid prescription post iv fluid guideline implementation as well as assessing the risks, benefits and harms of IV fluids. He will also look at reducing complications related to IV devices, identifying consequences of fluid mismanagement, line placement complications and rates and issues around catheter related thrombus: improving practice
19 March 2018